The "activation" of natural ingredients through a new catalytic procedure, has given rise to a series of molecules which have anti-viral effects against different types of vegetal and animal viruses. Several trials "in vivo" have been carried out with positive results against common viruses such as IPN (pancreatic necrosis of fingerlings), TGEV (intestinal gastroenteritis), HSV-2 (genital herpes), zoster herpes, influenza, etc.

The action of viruses induces the presence and action of oxidizing agents (free radicals). These agents produce "oxidative stress", causing cellular damage and being responsible for a big percentage of the virus pathogeny.

The molecules able to reduce the above-mentioned destructive effects of viruses are substances with an anti-oxidizing character ("activated" substances). These molecules act as oxidizing inhibitors by blocking the oxidizing process, the degradation of the immunological system and the viral replication.

The selected molecules for the tratment of influenza, asthma and sinusitis have a significant anti-oxidazing character which is enhanced by the "molecular activation" procedure.

The results obtained in persons with flu as well as in asthma and allergic patients have been veri satisfactory, widely overcoming the expectations of medical professionals. The continued medication with ASBRIP has resulted in a complete recovery of asthma and allergic patients, with total disappearance of symptoms in all cases.

INGREDIENTSL
emon Juice, Eucaliptus, Honey, Malic Acid, Fumaric Acid, Ascorbic Acid, Nipagin, Mint.

NUTRITIONAL AND ENERGY VALUE (per 100 ml)

DIRECTIONS

Shake before use.
ADULTS: 1 tablespoonful (10 ml) 3 times a day.
CHILDREN: 1 teaspoonful (5 ml) 3 times a day.

To be used alone or dissolved in a small quantity of water, infusion or fruit juice.

STORAGE
Keep bottle well closed and store in a fresh and dry place.

BIBLIOGRAPHY

1. "Evaluation of antioxidant healing formulations in topical therapy of experimental cutaneous and genital herpes simplex virus infections". J Sheridan, E. Kern, A. Martin, A. Booth. Antiviral Research 36, 157-166, 1997.

2. "Anti-hepatitis B activity of N-acetyl-L-Cysteine (NAC) New aspects of a well-established drug". Ludwig Weiss, Eberhard Hildt, Peter Hans Hofschneider. Antiviral Research 32, 43-53, 1996.

3. "Antiviral activity of glycyrrhizin against varicella zoster virus in vitro". Masanori Baba and Shiro Shigeta. Antiviral Research 7, 99-107, 1987.

4. "Antiviral activity of a D-glucosamine derivative against herpetic ulcers (USV type 2) in rabbit cornea". C. Pérez Martín, Pilar Vilas, Sara Pérez Prieto and Antonio Martín. Acta ophthalmologica 67, 55-60, 1989.